"Tranquil Clinical Research (CRO and Phase I Unit) was created to ensure that the entire clinical trial, device, and drug development process is conducted with ethics and the patient in mind first and always. TCR has a first of its kind patient centric inpatient Phase I Unit strategically located near the largest medical center in the world and in the most diverse city in the US and surrounded by 14 university/college systems."

During the past decade, Tranquil Clinical Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tranquil Clinical Research" #1 sponsor was "Atossa Therapeutics, Inc." with 1 trials, followed by "Bayer" with 1 trials sponsored, "BriaCell Therapeutics Corporation" with 1 trials sponsored, "Inventiva Pharma" with 1 trials sponsored and "Jazz Pharmaceuticals" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tranquil Clinical Research" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "InClin" with 1 trials as a collaborator and "LumaBridge" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Tranquil Clinical Research" are "Advanced Solid Tumor" (1 trials), "Breast Cancer" (1 trials), "Breast Cancer Metastatic" (1 trials), "Breast Neoplasm" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Tranquil Clinical Research" in a lesser frequency.

Most popular intervention types in "Tranquil Clinical Research" are "Drug" (7 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "IVA337" (1 trials), "Interferon Inoculation" (1 trials), "Kerendia (Finerenone, BAY94-8862)" (1 trials) and "Low dose cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tranquil Clinical Research" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Tranquil Clinical Research". undefined are not yet recruiting, 8 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tranquil Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tranquil Clinical Research, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".